Cargando…
Ivermectin treatment in humans for reducing malaria transmission
BACKGROUND: Malaria is transmitted through the bite of Plasmodium‐infected adult female Anopheles mosquitoes. Ivermectin, an anti‐parasitic drug, acts by killing mosquitoes that are exposed to the drug while feeding on the blood of people (known as blood feeds) who have ingested the drug. This effec...
Autores principales: | Souza, Dziedzom K, Thomas, Rebecca, Bradley, John, Leyrat, Clemence, Boakye, Daniel A, Okebe, Joseph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240090/ https://www.ncbi.nlm.nih.gov/pubmed/34184757 http://dx.doi.org/10.1002/14651858.CD013117.pub2 |
Ejemplares similares
-
An evaluation of Wb123 antibody elisa in individuals treated with ivermectin and albendazole, and implementation challenges in Africa
por: de Souza, Dziedzom Komi, et al.
Publicado: (2017) -
Ivermectin to reduce malaria transmission II. Considerations regarding clinical development pathway
por: Chaccour, Carlos, et al.
Publicado: (2017) -
Ivermectin to reduce malaria transmission III. Considerations regarding regulatory and policy pathways
por: Chaccour, Carlos, et al.
Publicado: (2017) -
Ivermectin to reduce malaria transmission I. Pharmacokinetic and pharmacodynamic considerations regarding efficacy and safety
por: Chaccour, Carlos, et al.
Publicado: (2017) -
Community-based trial of annual versus biannual single-dose ivermectin plus albendazole against Wuchereria bancrofti infection in human and mosquito populations: study protocol for a cluster randomised controlled trial
por: de Souza, Dziedzom K., et al.
Publicado: (2017)